Vertex Pharmaceuticals Incorporated (VRTX)

NMS – Real Time Price. Currency in USD

448.29

+13.12 (3.01%)

At close: May 12, 2026, 4:00 PM EDT

447.76

-0.53 (-0.12%)

Pre-market: May 13, 2026, 6:11 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

12.07B

10.98B

9.84B

8.75B

Cost of goods sold

-1.81B

-1.53B

-1.26B

-1.08B

Gross Profit

10.27B

9.45B

8.58B

7.67B

Operating expenses (excl. COGS)

-5.51B

-5.09B

-4.30B

-3.48B

Operating Income

4.76B

4.36B

4.28B

4.18B

Non-operating income, total

-118M

-4.11B

103M

37M

Pretax income

4.64B

249M

4.38B

4.23B

Equity in earnings

Taxes

-690M

-784M

-760M

-910M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

3.95B

-536M

3.62B

3.32B

Vertex Pharmaceuticals Incorporated (VRTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vertex Pharmaceuticals Incorporated (VRTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Vertex Pharmaceuticals Incorporated (VRTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vertex Pharmaceuticals Incorporated (VRTX)

Income Statement (Annual)

Income Statement (Annual)